Iranian Red Crescent Medical Journal

Published by: Kowsar

The Benefit of Therapeutic Drug Monitoring of Vancomycin in a Respiratory ICU; A Patient with Acute Kidney Injury: A Case Report

Lingti Kong 1 , Yulin Zhu 1 , * , Yong Zhang 2 and Haitao Liu 2
Authors Information
1 Department of Pharmacy, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China
2 Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China
Article information
  • Iranian Red Crescent Medical Journal: In Press (In Press); e62220
  • Published Online: November 17, 2018
  • Article Type: Case Report
  • Received: September 26, 2017
  • Revised: January 9, 2018
  • Accepted: January 23, 2018
  • DOI: 10.5812/ircmj.62220

To Cite: Kong L, Zhu Y, Zhang Y, Liu H. The Benefit of Therapeutic Drug Monitoring of Vancomycin in a Respiratory ICU; A Patient with Acute Kidney Injury: A Case Report, Iran Red Crescent Med J. Online ahead of Print ; In Press(In Press):e62220. doi: 10.5812/ircmj.62220.

Abstract
Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Introduction
2. Case Presentation
3. Discussion
Footnote
References
  • 1. Hicks RW, Hernandez J. Perioperative pharmacology: A focus on vancomycin. AORN J. 2011;93(5):593-6. quiz 597-9. doi: 10.1016/j.aorn.2010.09.031. [PubMed: 21530708].
  • 2. Rubinstein E, Keynan Y. Vancomycin revisited - 60 years later. Front Public Health. 2014;2:217. doi: 10.3389/fpubh.2014.00217. [PubMed: 25401098]. [PubMed Central: PMC4215627].
  • 3. Kane SP, Hanes SD. Unexplained increases in serum vancomycin concentration in a morbidly obese patient. Intensive Crit Care Nurs. 2017;39:55-8. doi: 10.1016/j.iccn.2016.08.004. [PubMed: 27899248].
  • 4. Sinha Ray A, Haikal A, Hammoud KA, Yu AS. Vancomycin and the risk of AKI: A systematic review and meta-analysis. Clin J Am Soc Nephrol. 2016;11(12):2132-40. doi: 10.2215/CJN.05920616. [PubMed: 27895134]. [PubMed Central: PMC5142072].
  • 5. Ye ZK, Tang HL, Zhai SD. Benefits of therapeutic drug monitoring of vancomycin: A systematic review and meta-analysis. PLoS One. 2013;8(10). e77169. doi: 10.1371/journal.pone.0077169. [PubMed: 24204764]. [PubMed Central: PMC3799644].
  • 6. Bruniera FR, Ferreira FM, Saviolli LR, Bacci MR, Feder D, da Luz Goncalves Pedreira M, et al. The use of vancomycin with its therapeutic and adverse effects: A review. Eur Rev Med Pharmacol Sci. 2015;19(4):694-700. [PubMed: 25753888].
  • 7. Seabury RW, Stoessel AM, Steele JM. Vancomycin trough concentration poorly characterizes AUC: Is it time to transition to AUC-based vancomycin monitoring? Ann Pharmacother. 2017;51(10):926-7. doi: 10.1177/1060028017716469. [PubMed: 28627271].
  • 8. Shahrami B, Najmeddin F, Mousavi S, Ahmadi A, Rouini MR, Sadeghi K, et al. Achievement of vancomycin therapeutic goals in critically Ill patients: Early individualization may be beneficial. Crit Care Res Pract. 2016;2016:1245815. doi: 10.1155/2016/1245815. [PubMed: 27073695]. [PubMed Central: PMC4814628].
  • 9. Alvarez R, Lopez Cortes LE, Molina J, Cisneros JM, Pachon J. Optimizing the clinical use of vancomycin. Antimicrob Agents Chemother. 2016;60(5):2601-9. doi: 10.1128/AAC.03147-14. [PubMed: 26856841]. [PubMed Central: PMC4862470].
  • 10. Ye ZK, Chen YL, Chen K, Zhang XL, Du GH, He B, et al. Therapeutic drug monitoring of vancomycin: A guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society. J Antimicrob Chemother. 2016;71(11):3020-5. doi: 10.1093/jac/dkw254. [PubMed: 27494905].
  • 11. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31-41. doi: 10.1159/000180580. [PubMed: 1244564].
  • 12. Brochard L, Abroug F, Brenner M, Broccard AF, Danner RL, Ferrer M, et al. An official ATS/ERS/ESICM/SCCM/SRLF statement: Prevention and management of acute renal failure in the ICU patient: An international consensus conference in intensive care medicine. Am J Respir Crit Care Med. 2010;181(10):1128-55. doi: 10.1164/rccm.200711-1664ST. [PubMed: 20460549].
  • 13. Barletta JF, Mangram AJ, Byrne M, Hollingworth AK, Sucher JF, Ali-Osman FR, et al. The importance of empiric antibiotic dosing in critically ill trauma patients: Are we under-dosing based on augmented renal clearance and inaccurate renal clearance estimates? J Trauma Acute Care Surg. 2016;81(6):1115-21. doi: 10.1097/TA.0000000000001211. [PubMed: 27533906].
  • 14. Kong L, Tang Y, Zhang X, Lu G, Yu M, Shi Q, et al. Pharmacokinetic/pharmacodynamic analysis of meropenem for the treatment of nosocomial pneumonia in intracerebral hemorrhage patients by Monte Carlo simulation. Ann Pharmacother. 2017;51(11):970-5. doi: 10.1177/1060028017719715. [PubMed: 28677407].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments